Drugs / levodopa/carbidopa
last change Nov 2009 re-read 2 minutes ago

levodopa/carbidopa

Developed for
Parkinson disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00906828 Comparator Oct 2008 → Nov 2009 Parkinson disease Uppsala University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as levodopa/carbidopa ClinicalTrials.gov intervention name — accepted as the source's own label NCT00906828
Route Other “intestinal gel, continuous infusion (daytime or 24-hour)” NCT00906828